Furthermore, EXT1 was shown to induce stemness in MCF-7 breast cancer cells associated with increased epithelial–mesenchymal transition and doxorubicin resistance, which could be antagonized by EXT1 downregulation [20]. Here, EXT1 is linked to breast cancer.